Data / Form D filings / Alto Labs LLC
Alto Labs LLC: Form D filing
Alto Labs LLC, a pharmaceuticals company in Los Angeles, CA, filed a Form D with the SEC in 2025. The latest, on October 2, 2025, reports $300,000 sold of a $400,000 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1801 S HILL STREET #200,, Los Angeles, CA, 90007
- Phone
- (310) 709-1427
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Texas
- Year incorporated
- 2023
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2089151
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | New notice | $400,000 | $300,000 | $100,000 | 2 | Aug 14, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Adam Solomon | Executive Officer | |
| Matthew Makabeh | Executive Officer | |
| Oliver Cohen | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 29, 2025 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Alto Labs LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.